'김갑성' 기자의 전체기사
-
LISCure Biosciences Initiates Global Phase 2 Trial of LB-P8 in…
SEOUL, South Korea, Nov. 10, 2025 -- LISCure Biosciences ("LISCure"), a clinical-stage biopharmaceutical company, announced the initiation of patient dosing in a global Phase 2 clinical trial of LB-P8, a novel therapeutic candidate for Primary Sclerosing Cholangitis (PSC), a rare and progressive liver disease with no approved treatments on November 5 (local time in the U.S.). LB-P8: A First in Class Candidate Targeting the Gut-Liver axis PSC is a cholestatic liver disease of unknown etiology, characterized by inflammation and fibrosis of the bile d
- 김갑성 기자
- 2025-11-10 20:00
-
Akeso Announces First Patient Dosed in Phase I Trial of Pers…
HONG KONG, Nov. 10, 2025 -- Akeso, Inc. (HKEX: 9926. HK) is pleased to announce that the first patient has been dosed in a Phase I clinical trial evaluating the personalized mRNA vaccine AK154. This trial is investigating AK154 both as a monotherapy and as a combination with the company's first-in-class bispecific antibodies, cadonilimab (PD-1/CTLA-4) and ivonescimab (PD-1/VEGF), for the adjuvant treatment of pancreatic cancer following surgical resection. AK154 is Akeso's first mRNA-based therapeutic candidate to enter clinical development. This achievement marks a significant breakth
- 김갑성 기자
- 2025-11-10 19:39
-
MediTrust Health and Sino Biopharm Sign Strategic Cooperat…
HONG KONG, Nov. 10, 2025 -- Shanghai, November 10, 2025 – During the 8th China International Import Expo (CIIE), Sino Biopharmaceutical Limited ("Sino Biopharm") and Shanghai MediTrust Health Technology Group Co., Ltd. ("MediTrust Health") signed a strategic cooperation agreement. The two parties will carry out in-depth cooperation around innovative drugs and commercial insurance, jointly explore a new model of drug-insurance integration, and help more patients access high-quality, affordable medicines at an earlier stage. Mr. Tse Hsin, Executive Director an
- 김갑성 기자
- 2025-11-10 14:18
-
Jiahui International Cancer Center Attracts Global Patients with…
SHANGHAI, Nov. 10, 2025 -- On November 7, Jiahui International Cancer Center (JICC) successfully treated a 78-year-old patient from New Zealand with relapsed multiple myeloma using CAR-T therapy, highlighting JICC's growing reputation as a destination for cutting-edge oncology care for international patients. The patient received Zevor-cel (Zevor-cel Injection) CAR-T therapy and was discharged in stable condition. The patient, a retired family medicine doctor with 40 years of experience, had exhausted all conventional treatment options in his home country. Following a recommendation fr
- 김갑성 기자
- 2025-11-10 14:09
-
Rona Therapeutics Presents Phase 1 Data for RN0361, a Lon…
NEW ORLEANS, Nov. 10, 2025 -- Rona Therapeutics, a global leader in developing next-generation RNAi therapeutics, presented highlights of Phase 1 clinical data for RN0361, a long-acting Apolipoprotein C3 (ApoC3) siRNA. RN0361 achieved potent, durable reductions in ApoC3 and triglycerides (TG) lasting at least six months in a single dose first-in-human trial, establishing a potential best-in-class profile to prevent pancreatitis in severe hypertriglyceridemia (HTG) and reduce cardiovascular risk (CVD) from atherogenic lipoproteins. The data were presented today at the American Heart Associatio
- 김갑성 기자
- 2025-11-10 12:00
-
Kelun-Biotech Presented TROP2 ADC Sacituzumab Tirumotec…
CHENGDU, China, Nov. 10, 2025 -- From November 6 to 9, the 2025 Chinese Congress on Holistic Integrative Oncology (CCHIO) was held in Kunming, Yunnan. This conference was jointly organized by the Chinese Anti-Cancer Association (CACA), the Tengchong Science Forum Organizing Committee Office, the World Association for Integrative Oncology (WAIO), and the China Institute for Integrative Medicine Development Strategy. Academicians, experts, and scholars from across the nation gathered to focus on innovations in cancer diagnosis and treatment while sharing scientific breakthroughs. At the
- 김갑성 기자
- 2025-11-10 10:01
-
ICP DAS-BMP Attends MOU Signing Ceremony to Mark a New Milesto…
HSINCHU, Nov. 10, 2025 -- ICP DAS-BMP participated in the Strategic Memorandum of Understanding (MOU) signing ceremony organized by Towards Buddha Co., Ltd. on October 28, where it showcased its R&D achievements and diverse applications in medical-grade TPU materials. Moving forward, ICP DAS-BMP will collaborate with industry experts and think-tank teams to foster innovation and jointly drive the development and wider adoption of TPU materials in global markets. The event brought together industry partners including ICP DAS CO., LTD. / ICP DAS-BMP, Intype Enterprise
- 김갑성 기자
- 2025-11-10 08:45
-
ICP DAS-BMP, 의료용 TPU 소재의 새로운 이정표 위한 MOU 체결식에 참석
신주 2025년 11월 10일 -- ICP DAS-BMP가 지난 10월 28일 투워드 부다((Toward Buddha Co., Ltd.)가 주최한 전략적 양해각서(MOU) 체결식에 참석해 의료용 TPU(열가소성 폴리우레탄) 소재의 연구개발 성과와 다양한 응용 분야를 선보였다. 향후 ICP DAS-BMP는 업계 전문가 및 싱크탱크 팀과 협력해 혁신을 촉진하고, TPU 소재의 개발과 글로벌 시장 확산을 공동으로 추진할 예정이다. 이번 행사에는 ICP DAS CO., LTD. / ICP DAS-BMP, 인타입 엔터프라이즈(Intype Enterprise Co., Ltd.), 에이-맥스 테크놀로지(A-MAX Technology Co., Ltd.), 메드서브 바이오텍(MedServ Biotech Co., Ltd.), 레온 바이오텍(LEON Biotech Co., Ltd.), 볼러 바이오텍 컨설팅(VOLER Biotech Consulting Co., Ltd.), 치펑(Chi Feng Co., Ltd.), 투워즈버다(Toward Buddha Co., Ltd.) 등 업계 주요 파트너들이 참석했다. 이들 기업은 의료용
- 김갑성 기자
- 2025-11-10 08:45
-
피죤, CIIE 2025서 '둥지' 주제로 혁신적 수유•유아 돌봄 과학 공개
[ 메디채널 김갑성 기자 ] 상하이 2025년 11월 8일 -- 고품질•정밀 설계된 유아 및 임산부용 제품 분야에서 신뢰받는 글로벌 선도기업 피죤(Pigeon)이 상하이 국가전시컨벤션센터(National Exhibition and Convention Center)에서 열린 제8회 중국국제수입박람회(China International Import Expo•CIIE)에서 '둥지(The Nest)'라는 주제로 수유 및 유아 돌봄 과학 분야의 최신 성과를 선보였다. 중국 진출 23년 맞은 피죤, 현지 혁신에서 글로벌 리더십으로 확장 CIIE 소비재 전시관(6.1관)에서 피죤의 아기 젖병은 관람객들로부터 큰 주목을 받았다. 저우지안펑(Zhou Jianfeng) 피죤 차이나 사장은 올해 중국 진출 23년을 맞이한 피죤이 그동안 걸어온 길에 대해 이렇게 말했다. "피죤은 일본에서 직접 제품을 가져오면서 중국에서의 여정을 시작했다. 시간이 흐르면서 중국 내에서 제조 시설 3곳과 연구개발(R&D) 센터를 1곳을 구축하고, 첨단 기술과 품질 시스템을 도입해 현지 가정에 신뢰할 수 있는 솔루션을 제공하기
- 김갑성 기자
- 2025-11-08 21:34
-
Xinhua Silk Road: E. China's Weihai City establishes 18 TCM h…
BEIJING, Nov. 8, 2025 -- Weihai, a prefecture-level city in east China's Shandong Province, has seen the establishment of 18 traditional Chinese medicine (TCM) health tourism demonstration bases, including the Weihai Tianmu Hot Spring Resort, as the city has emphasized the deep integration of tourism with TCM and health and wellness in recent years. The forest coverage here is high and the environment is beautiful, said a tourist from Qingdao who was on a tour with her friends in the Weihai Tianmu Hot Spring Resort, adding that she and her friends had experienced the hot spring here wh
- 김갑성 기자
- 2025-11-08 20:48
- 1포리프 굿마팻 (누바디 굿바이 마이팻) 다이어트 건강기능식품 출시
- 22021년 식품분석전문가 1급/2급 검정자격시험 안내
- 3투썸플레이스, 초콜릿 애프리콧 무스 출시
- 4아임웹, CRM 기능 출시… 고객 행동 데이터 기반 마케팅 지원
- 5하만카돈, AURA STUDIO 4 블루투스 스피커 출시
- 6대구오페라하우스 - 20주년 기념 골든 보이스 시리즈Ⅲ, 테너 콘서트
- 7만성질환자들의 유료독감백신접종에 정책적인 배려가 필요하다
- 82021년 대학생기자단 모집
- 9대한약물영양의학회 2020년 추계학술대회
- 10대한영양제처방학회 춘계학술대회 성황리에 마쳐
2026-01-31_SAT
- 도코모, 아두나와 글로벌 네트워크 API 확장을 위한 파트너십 계약 체결 23:19
- JOHNNIE WALKER TOASTS MUSIC'S BIGGEST WEEKEND WITH THE GO GO HIGHBALL 20:58
- Sanyou Bio's Decade: From an Intelligent Super-Trillion Antibody Library to the "Innovation Hub for Original Drug Discovery" 16:15
- CANADA BACKS NEW DEFENCE, SECURITY AND RESILIENCE BANK 12:05
- Origin Agritech Announces Fiscal Year 2025 Results 06:00
- White Pearl Acquisition Corp. Announces Pricing of $100 Million Initial Public Offering 05:47
- Planet Green Holdings Corp. Provides Response to Unusual Market Action 05:05
발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.
UPDATE: 2026년 02월 01일 00시 50분